NEW YORK (Reuters Health) – Prospective study results suggest that saquinavir is the only older protease inhibitor (PI) not associated with an increased risk of myocardial infarction (MI).…
NEW YORK (Reuters Health) – Decreases in hemoglobin after transradial percutaneous coronary intervention (PCI) are minor in most patients, researchers from Quebec Heart-Lung Institute report in the July…
NEW YORK (Reuters Health) – Cardiologists should perform percutaneous coronary intervention (PCI) as soon as possible if initial treatment for ST-segment elevation myocardial infarction (STEMI) is thrombolysis, researchers…
NEW YORK (Reuters Health) The earlier a patient with ST-segment elevation myocardial infarction (STEMI) receives clopidogrel before primary coronary intervention (PCI), the better, according to a study in…
NEW YORK (Reuters Health) Central venous oxygen saturation (ScvO2) can’t be reliably estimated via catheters inserted through the femoral vein, researchers report in the July issue of Chest…
NEW YORK (Reuters Health) – Outcomes are better for patients with total coronary artery occlusions when percutaneous coronary intervention is performed with sirolimus-eluting stents rather than with bare…
NEW YORK (Reuters Health) – Eptifibatide and tirofiban are effective alternatives to abciximab given during primary percutaneous intervention for ST-elevation MI, according to the results of a meta-analysis…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer who have not had a recurrence for 5 years after resection may not yet be free and clear.…
NEW YORK (Reuters Health) – In managing hospitalized patients who develop candidemia, the standard practice of promptly removing a central venous catheter does not improve outcomes, according a…
NEW YORK (Reuters Health) – Patients with chronic heart failure have a higher mortality risk or are more likely to undergo a heart transplant if they have low…